SCHEMBL30645201

SCHEMBL30645201

Brc1ccc(OCCN2CCNCC2)nc1.CC(C)(C)OC(=O)N1CCN(CCOc2ccc(Br)cn2)CC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP4F2 P78329 1/20 0.48
▸ GPR119 Q8TDV5 5/20 0.42
▸ GPR4 P46093 1/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.41
▸ DGAT1 O75907 1/20 0.40
▸ EPHX2 P34913 4/20 0.40
▸ HRH2 P25021 1/20 0.39
▸ HRH1 P35367 1/20 0.39
▸ HTR1B P28222 1/20 0.39
▸ CHRM2 P08172 1/20 0.39
▸ CHRM4 P08173 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ CHRM3 P20309 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ SQOR Q9Y6N5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31210120 0.94 CYP4F2 (0.50) CYP4F2GPR119GPR4RXFP1DGAT1
SCHEMBL16111442 0.94 CYP4F2 (0.50) CYP4F2GPR119GPR4RXFP1DGAT1
SCHEMBL23649400 0.89 HRH2 (0.50) CYP4F2GPR119DGAT1EPHX2HRH2
SCHEMBL30433080 0.89 HRH2 (0.50) CYP4F2GPR119DGAT1EPHX2HRH2
SCHEMBL31210089 0.82 LTA4H (0.46) KDM4ETDP1
SCHEMBL26690765 0.82 LTA4H (0.46) KDM4ETDP1
SCHEMBL25399048 0.81 CYP4F2 (0.50) CYP4F2GPR119GPR4RXFP1EPHX2
SCHEMBL27380506 0.81 GPR119 (0.48) CYP4F2GPR119GPR4HRH2HRH1
SCHEMBL27380536 0.79 GPR119 (0.49) CYP4F2GPR119GPR4RXFP1EPHX2
SCHEMBL31212755 0.79 GPR119 (0.50) GPR119DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4514782-A1 AMIDO HETEROAROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF LIVER DISEASES Astrazeneca AB (SE) 2025-03-05 — — EP disclosed
WO-2023222850-A1 AMIDO HETEROAROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF LIVER DISEASES ASTRAZENECA AB (SE) 2023-11-23 — — WO disclosed
Send feedback